Validation study demonstrates reliability and validity of the ASCQ-Me tool in sickle cell disease, indicating its suitability for clinical assessment.
The analysis of the sample shows evidence of both validity and reliability of the ASCQ-Me for use in the UK SCD population.
No takes yet. Share an insight, caveat, or question.
Cooper et al. (2019) studied this question.